News Website

4 chilling details about the Taylor Parker case missing from “Maternal Instinct” - Yahoo

4 chilling details about the Taylor Parker case missing from “Maternal Instinct” Yahoo

Published: June 24, 2026, 10:31 p.m.

Read Full Article

Exclusive BAC Article: Absci Corporation; Positive Phase 1 Data ABS-201 AGA, Interim And Final POC Data 2nd Half 2026/Early 2027, Respectively, Advancement Endometriosis And Catalysts (NASDAQ:ABSI) - Seeking Alpha

Exclusive BAC Article: Absci Corporation; Positive Phase 1 Data ABS-201 AGA, Interim And Final POC Data 2nd Half 2026/Early 2027, Respectively, Advancement Endometriosis And Catalysts (NASDAQ:ABSI) Seeking Alpha

Published: June 24, 2026, 7:18 p.m.

Read Full Article

Absci Announces Positive Interim Phase 1 Data from the HEADLINE™ Trial of ABS-201, a Novel Antibody Targeting the Prolactin Receptor (PRLR) - markets.businessinsider.com

Absci Announces Positive Interim Phase 1 Data from the HEADLINE™ Trial of ABS-201, a Novel Antibody Targeting the Prolactin Receptor (PRLR) markets.businessinsider.com

Published: June 24, 2026, 11:25 a.m.

Read Full Article

Absci stock surges 24% on positive Phase 1 hair loss drug data - Investing.com South Africa

Absci stock surges 24% on positive Phase 1 hair loss drug data Investing.com South Africa

Published: June 24, 2026, 11:14 a.m.

Read Full Article

Absci stock surges 24% on positive Phase 1 hair loss drug data By Investing.com - Investing.com India

Absci stock surges 24% on positive Phase 1 hair loss drug data By Investing.com Investing.com India

Published: June 24, 2026, 11:13 a.m.

Read Full Article

Absci Announces Positive Interim Phase 1 Data from the HEADLINE™ Trial of ABS-201, a Novel Antibody Targeting the Prolactin Receptor (PRLR) - The Manila Times

Absci Announces Positive Interim Phase 1 Data from the HEADLINE™ Trial of ABS-201, a Novel Antibody Targeting the Prolactin Receptor (PRLR) The Manila Times

Published: June 24, 2026, 10:48 a.m.

Read Full Article

Absci Reports Positive Phase 1 Results for ABS-201, a First-in-Class PRLR Antibody for Hair Regrowth and Endometriosis – Minichart - Minichart

Absci Reports Positive Phase 1 Results for ABS-201, a First-in-Class PRLR Antibody for Hair Regrowth and Endometriosis – Minichart Minichart

Published: June 24, 2026, 10:45 a.m.

Read Full Article

Taking the combined oral contraceptive pill can increase binge eating, study suggests - MSN

Taking the combined oral contraceptive pill can increase binge eating, study suggests MSN

Published: June 24, 2026, 10:43 a.m.

Read Full Article

Catheter-Based OCT May Help ID Early Endometrial Cancer - Ophthalmology Advisor

Catheter-Based OCT May Help ID Early Endometrial Cancer Ophthalmology Advisor

Published: June 24, 2026, 4 a.m.

Read Full Article

Macrophage-derived exosomes promote proliferation, migration, and invasion of endometrial stromal cells in endometriosis and are associated with exosomal lncRNA ZFAS1: A pilot translational study.

Endometriosis (EMs) is a prevalent gynecological disorder affecting reproductive-age women. Exosomes secreted by peripheral blood macrophages may participate in EMs progression. In this pilot translational study, exosomes from peripheral blood …

Published: June 24, 2026, midnight

Read Full Article

endometrial stromal cells endometriosis exosomes lncRNA ZFAS1 peripheral blood macrophages

Latest Articles

4 chilling details about the Taylor Parker case missing from “Maternal Instinct” - Yahoo

Exclusive BAC Article: Absci Corporation; Positive Phase 1 Data ABS-201 AGA, Interim And Final POC Data 2nd Half 2026/Early 2027, Respectively, Advancement Endometriosis And Catalysts (NASDAQ:ABSI) - Seeking Alpha

Absci Announces Positive Interim Phase 1 Data from the HEADLINE™ Trial of ABS-201, a Novel Antibody Targeting the Prolactin Receptor (PRLR) - markets.businessinsider.com

Absci stock surges 24% on positive Phase 1 hair loss drug data - Investing.com South Africa

Absci stock surges 24% on positive Phase 1 hair loss drug data By Investing.com - Investing.com India

Absci Announces Positive Interim Phase 1 Data from the HEADLINE™ Trial of ABS-201, a Novel Antibody Targeting the Prolactin Receptor (PRLR) - The Manila Times

Absci Reports Positive Phase 1 Results for ABS-201, a First-in-Class PRLR Antibody for Hair Regrowth and Endometriosis – Minichart - Minichart

Taking the combined oral contraceptive pill can increase binge eating, study suggests - MSN

Catheter-Based OCT May Help ID Early Endometrial Cancer - Ophthalmology Advisor

Macrophage-derived exosomes promote proliferation, migration, and invasion of endometrial stromal cells in endometriosis and are associated with exosomal lncRNA ZFAS1: A pilot translational study.

Subscribe to Our Newsletter